Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards up to $1.8M for Single-cell Genomics of Malaria

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded $1.8 million to Texas Biomedical Research Institute scientist Ian Cheeseman to continue research on single-cell genomics of malaria parasites.

The R01 grant awards Cheeseman and his colleagues $450,000 the first year, and potentially up to $1.8 million over four years, to perform further research on a method to sequence the genomes of individual malaria parasites, a method they developed and published in May in Genome Research. The method combines cell sorting and whole-genome amplification to generate samples for genotyping and next-generation sequencing.

Single-cell genomics was pioneered in cancer research to identify how tumors evolve during the progression of a disease. The development of a single-cell genomic approach to malaria will allow scientists to better characterize the particular parasites infecting patients, according to TBRI. Each malaria infection can contain multiple, genetically distinct strains of malaria parasites. For example, one factor that can differ between strains is the presence of drug resistance genes.

"We think about these infections as containing the sort of diversity you would see in a human village. We could previously only look at the village as a whole, but new technology developed here at Texas Biomed now allows us to identify everyone in the village directly," Cheeseman said in a statement. "This will help us understand how to best design drugs and vaccines to tackle this major global killer."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.